表紙:血管閉鎖デバイスの世界市場 - 市場規模・シェア・動向分析:タイプ別、アクセス別、処置別、地域別の見通し、競合戦略、セグメント予測 (2030年まで)
市場調査レポート
商品コード
1046434

血管閉鎖デバイスの世界市場 - 市場規模・シェア・動向分析:タイプ別、アクセス別、処置別、地域別の見通し、競合戦略、セグメント予測 (2030年まで)

Global Vascular Closure Device Market Size, Share & Trends Analysis Report By Type, By Access, By Procedure, Regional Outlook, Competitive Strategies and Segment Forecast - 2030

出版日: | 発行: SPER Market Research Pvt. Ltd. | ページ情報: 英文 206 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.41円
血管閉鎖デバイスの世界市場 - 市場規模・シェア・動向分析:タイプ別、アクセス別、処置別、地域別の見通し、競合戦略、セグメント予測 (2030年まで)
出版日: 2022年01月12日
発行: SPER Market Research Pvt. Ltd.
ページ情報: 英文 206 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 目次
概要

世界の血管閉鎖デバイスの市場規模は、2021年の11億2,000万米ドルから、2030年までに15億8,000万米ドルに達し、CAGRで7.4%の成長が予測されています。心血管障害の世界的な負担は、世界中で年間約1,700万人の死亡を引き起こしています。心血管障害の患者数は、高齢者人口の増加に伴い、今後数年間で増加し続けると予想されます。

当レポートでは、世界の血管閉鎖デバイス市場について調査分析し、市場概要、促進要因・課題・機会、市場分析、主要企業などについて、体系的な情報を提供しています。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

  • イントロダクション
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
    • 課題
  • 血管閉鎖デバイス市場に対するCOVID-19の影響
  • 市場動向

第5章 世界の血管閉鎖デバイス市場:タイプ別 (2021年~2030年)

  • パッシブアプロキシメーター
  • アクティブアプロキシメーター
  • 外部止血デバイス

第6章 世界の血管閉鎖デバイス市場:アクセス別 (2021年~2030年)

  • 大腿骨
  • 橈骨

第7章 世界の血管閉鎖デバイス市場:処置別 (2021年~2030年)

  • インターベンショナルカーディオロジー
  • インターベンショナルラジオロジー/血管手術

第8章 世界の血管閉鎖デバイス市場:地域別 (2021年~2030年)

  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他の欧州
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • その他のアジア太平洋地域
  • その他の地域
    • ラテンアメリカ
    • 中東・アフリカ

第9章 競合情勢

  • イントロダクション
  • 市場シェア分析:主要企業別 (2021年)
  • 競合シナリオ

第10章 企業プロファイル

  • Abbott, Cardinal Health
  • Advanced Vascular Dynamics
  • Boston Scientific Corporation
  • Cardiva Medical, Inc.
  • Marine Polymer Technologies, Inc.
  • Medas USA
  • Medtronic
  • Meril Life Sciences Pvt. Ltd.
  • Merit Medical Systems, Inc.
  • Morris Innovative, Inc.
  • Rex Medical
  • Scion BioMedical
  • Teleflex Incorporated
  • Terumo Corporation
  • Transluminal Technologies
  • Tricol Biomedical
  • TZ Medical
  • Vasorum Ltd.
  • Vivasure Medical Ltd.
  • Vygon Company

第11章 付録

目次
Product Code: MEDE2202

Global vascular closure device market is projected to worth USD 1.58 Bn by 2030.

According to SPER Market Research, the global vascular closure device market was valued at USD 1.12 Bn in 2021 and estimated to reach USD 1.58 Bn by 2030 with a CAGR of 7.4%. The global burden of cardiovascular disorders causes around 17 Mn deaths per year across the globe. The number of patients with cardiovascular disorder will continue to grow as the geriatric population will increase in coming years.

Impact of COVID-19 on the Vascular Closure Device Market

The upsurge in COVID-19 infections across the world redirect the resources and professionals towards COVID relief thus, compromising with wound care services, and elective surgeries. The temporary denial is notified for all the non-emergent healthcare services. Enforcing of lockdowns, curfews and fear of getting infected restrict the patients to visit hospitals, clinics or OPDs.

Scope of Report:

  • Market size available for years: 2019-2030
  • Base year considered: 2021
  • Forecast period: 2022-2030

Segments covered

By Type, By Access, By Procedure.

Geographies covered

North America, Europe, APAC, Latin America, and the Middle East & Africa.

Companies Covered: Abbott, Cardinal Health, Medtronic, TZ Medical, Merit Medical Systems, Inc., Rex Medical, Vygon Company, Vasorum Ltd., Terumo Corporation, Cardiva Medical, Inc., Boston Scientific Corporation, Scion BioMedical, Morris Innovative, Inc., Vivasure Medical Ltd., Teleflex Incorporated, Tricol Biomedical, Transluminal Technologies, Meril Life Sciences Pvt. Ltd., Medas USA, Advanced Vascular Dynamics, Marine Polymer Technologies, Inc.

Driver: Rising prevalence of cardiovascular diseases

High occurrence of cardiovascular diseases across the world will render high growth of vascular closure devices market in the forecast period. Rising prevalence of obesity, increasing geriatric population is leading to higher number of patients suffering from cardiovascular diseases.

Challenge: High medical costs and risk associated with vascular closure devices

The high costs of vascular closure devices can hinder the growth of this market. Countries with poor reimbursement policies can pose significant challenge for the adaption of vascular closure devices. The risks associated with the use of vascular closure devices during surgical procedures such as infections, bleeding, device failures and thrombotic events can also restrict the estimated growth.

Opportunity: Rising demand for minimally invasive procedures

The vascular closure devices provide minimal invasion and reduces risk of excessive blood loss during the surgeries. The rising awareness of patients towards minimally invasive procedures will provide growth opportunities for this market. Rising number of hospitals and healthcare funding will also support the growth of vascular closure devices.

Vascular Closure Devices Market by Product type:

Based on product type, the market has been segmented into passive approximators, active approximators and external Hemostatic Devices.

Vascular Closure Devices Market by Access:

Based on access, the market has been segmented into femoral access and radial access.

Vascular Closure Devices Market by Procedures:

Based on procedures, the market has been segmented into interventional cardiology and interventional radiology/vascular surgery.

Vascular Closure Devices Market by Region:

North America accounted for the largest share of Vascular Closure devices market. The large share is ascribed by sophisticated infrastructure, increasing prevalence of cardiovascular diseases and presence of leading players of this market in this region.

Table of Contents

1. Introduction

2. Research Methodology

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Market Dynamics
    • 4.2.1. Drivers
    • 4.2.2. Restraints
    • 4.2.3. Opportunities
    • 4.2.4. Challenges
  • 4.3. COVID-19 Impact of the Vascular Closure Device Market
  • 4.4. Market Trends

5. Global Vascular Closure Device Market, By Type, 2021-2030 (USD Million)

  • 5.1. Passive Approximators
    • 5.1.1. Cotton plugs
    • 5.1.2. Sealant or gel-based devices
    • 5.1.3. Compression assists devices
  • 5.2. Active Approximators
    • 5.2.1. Suture-based devices
    • 5.2.2. Clip-based devices
  • 5.3. External Hemostatic Devices

6. Global Vascular Closure Devices Market, By Access, 2021-2030 (USD Million)

  • 6.1. Femoral Access
  • 6.2. Radial Access

7. Global Vascular Closure Devices Market, By Procedures, 2021-2030 (USD Million)

  • 7.1. Interventional Cardiology
  • 7.2. Interventional Radiology/Vascular Surgery

8. Global Vascular Closure Devices Market, By Geography, 2021-2030 (USD Million)

  • 8.1. North America
    • 8.1.1. US
    • 8.1.2. Canada
  • 8.2. Europe
    • 8.2.1. Germany
    • 8.2.2. UK
    • 8.2.3. France
    • 8.2.4. Italy
    • 8.2.5. Spain
    • 8.2.6. Rest of Europe
  • 8.3. Asia-Pacific
    • 8.3.1. China
    • 8.3.2. Japan
    • 8.3.3. India
    • 8.3.4. Rest of Asia-Pacific
  • 8.4. Rest of the World
    • 8.4.1. Latin America
    • 8.4.2. Middle East & Africa

9. Competitive Landscape

  • 9.1. Introduction
  • 9.2. Market Share Analysis, By Key Players (2021)
  • 9.3. Competitive Scenario
    • 9.3.1. Product Launches
    • 9.3.2. Partnerships, Collaborations and Agreements
    • 9.3.3. Acquisitions
    • 9.3.4. Expansions
    • 9.3.5. Other Developments

10. Company Profiles

  • 10.1. Abbott, Cardinal Health
  • 10.2. Advanced Vascular Dynamics
  • 10.3. Boston Scientific Corporation
  • 10.4. Cardiva Medical, Inc.
  • 10.5. Marine Polymer Technologies, Inc.
  • 10.6. Medas USA
  • 10.7. Medtronic
  • 10.8. Meril Life Sciences Pvt. Ltd.
  • 10.9. Merit Medical Systems, Inc.
  • 10.10. Morris Innovative, Inc.
  • 10.11. Rex Medical
  • 10.12. Scion BioMedical
  • 10.13. Teleflex Incorporated
  • 10.14. Terumo Corporation
  • 10.15. Transluminal Technologies
  • 10.16. Tricol Biomedical
  • 10.17. TZ Medical
  • 10.18. Vasorum Ltd.
  • 10.19. Vivasure Medical Ltd.
  • 10.20. Vygon Company

11. Appendix